Atopic dermatitis
Conditions
Interventions
Apply topical steroid cream (PVA-N11) twice a day for 2 weeks.
Apply active comparator twice a day for 2 weeks.
Sponsors
Exam CO.,LTD
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients with atopic dermatitis. 2) Patients with mild or moderate rash on test site (both arms).
Exclusion criteria
Exclusion criteria: 1) Patients with severe skin disorders on test site (both arms) and deemed inappropriate to participate in this study by the principal investigator or sub-investigators. 2) Patients with any complications which affect the results of this study. 3) Patients who might use any external use medicines, anti-allergy drugs, or immunosuppressants. 4) Pregnant or lactating patients. Patients with suspicion of pregnancy. 5) Patients deemed inappropriate to participate in this study by the principal investigator or sub-investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity classification (simple method) of atopic dermatitis developed by the advisory committee of atopic dermatitis severity classification of Japanese Dermatological Association at test site (both arms) before and after the two-week application. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Transepidermal water loss, water content of the stratum corneum, erythema and pigmentation, and skin surface topography at test site (both arms) before and after the one- and the two-week application. 2) Questionnaires for QOL assessment in atopic dermatitis before and after the one- and the two-week application, and two weeks after the end of application. | — |
Countries
Japan
Contacts
Public ContactYukiyoshi Katsumata
Exam CO.,LTD DermaLabo
Outcome results
None listed